| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Radiology and Nuclear Medicine, Neuropathology (G.S.-D.) and Psychiatry (M.B.), Universitätsklinikum Benjamin Franklin, Free University of Berlin, and the Department of Medicine (K.-J.G.), Universitätsklinikum Rudolf Virchow, Humboldt University, 12200 Berlin, Germany
Address all correspondence and requests for reprints to: Dr. Andreas Baumgartner, Department of Radiological Diagnostics and Nuclear Medicine, Hindenburgdamm 30, 12200 Berlin, Germany.
In this article we describe the development of a highly sensitive, accurate, and reproducible RIA for the measurement of 3,3'-diiodothyronine (3,3'-T2) in human serum and brain tissue. The detection limits were 1.8 fmol/g and 1.5 pmol/L in human brain tissue and serum, respectively.
Serum concentrations of 3,3'-T2 were measured in 4 groups of patients with nonthyroidal illnesses (NTI), i.e. brain injuries (n = 15), sepsis (n = 24), liver disease (n = 22), and brain tumors (n = 23). The mean serum concentration of 3,3'-T2 in 62 healthy controls was 46.6 ± 20.0 pmol/L. 3,3'-T2 levels declined significantly with increasing age. They were significantly lower in patients with brain injury (34.2 ± 19.4 pmol/L; P = 0.006), were at the upper limit of normal in patients with sepsis (57.0 ± 36.9 pmol/L; P = 0.06), and were elevated in patients with liver disease (72.6 ± 56.7 pmol/L; P = 0.04) and brain tumors (89.0 ± 40.9 pmol/L; P = 0.01). The serum levels of T3 were significantly lower than those in controls in all 4 patient groups. Serum concentrations of 3,3'-T2 were significantly enhanced in 9 patients with hyperthyroidism (85.4 ± 43.0 pmol/L; P = 0.01) and were reduced in 12 patients with hypothyroidism (14.9 ± 9.2 pmol/L; P = 0.001). In both normal brain tissue, obtained either intraoperatively or excised postmortem, and brain tumors, the concentrations of 3,3'-T2 ranged between 50300 fmol/g. In healthy controls, 2 different forms of acute stress (sleep deprivation and delivering a lecture) significantly increased serum levels of T4 and T3, but did not affect those of 3,3'-T2 or 3,5-T2.
In conclusion, our results show that, contrary to expectation, a low T3 syndrome in NTI is not always associated with low serum concentrations of 3,3'-T2. The production of 3,3'-T2 in NTI seems to be regulated in a disease-specific manner, resulting in unchanged, reduced, or elevated hormone concentrations.
This article has been cited by other articles:
![]() |
T. Flatt, L. L. Moroz, M. Tatar, and A. Heyland Comparing thyroid and insect hormone signaling Integr. Comp. Biol., December 1, 2006; 46(6): 777 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pinna, O. Brodel, T. Visser, A. Jeitner, H. Grau, M. Eravci, H. Meinhold, and A. Baumgartner Concentrations of Seven Iodothyronine Metabolites in Brain Regions and the Liver of the Adult Rat Endocrinology, May 1, 2002; 143(5): 1789 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moreno, A. Lombardi, L. Beneduce, E. Silvestri, G. Pinna, F. Goglia, and A. Lanni Are the Effects of T3 on Resting Metabolic Rate in Euthyroid Rats Entirely Caused by T3 Itself? Endocrinology, February 1, 2002; 143(2): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eravci, G. Pinna, H. Meinhold, and A. Baumgartner Effects of Pharmacological and Nonpharmacological Treatments on Thyroid Hormone Metabolism and Concentrations in Rat Brain Endocrinology, March 1, 2000; 141(3): 1027 - 1040. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |